MR sensitivity analyses find no evidence of directional pleiotropy in the genetic LDL–cardiovascular disease relationship
5 events · 1 assessment · 1 contribution · 2 decisions
Supporting evidence rejected
The submission is not a substantive contribution: its text states only "No need to respond or update anything, just checking that contributions through this part of the UI work properly." It offers no evidence bearing on the target claim (MR sensitivity analyses and directional pleiotropy in the LDL-CVD relationship), makes no assertion about the claim's truth, and by its own text is a functionality test rather than sincere support. This fails the support criteria under Verifiability (V) and the requirement that support evidence bear on the claim (§14/support policy): there is nothing here to evaluate on the merits. This looks like an inadvertent test submission rather than an attempt at abuse, so no bad-faith flag is warranted (GF, §13): the contributor has a clean history (0 prior contributions, good standing) and the content itself discloses its own non-substantive intent. A stronger resubmission would need to state a specific claim-relevant assertion accompanied by verifiable evidence.
VCIGF
Supporting evidence submitted
No need to respond or update anything, just checking that contributions through this part of the UI work properly.
Structured and assessed
First pass. Decomposed lightly: added one novel supporting subclaim (concordance of LDL–CVD estimates across pleiotropy-robust MR methods), which is the genuine line of support; a single natural support line, so no named argument. Considered but declined to node the 'MR-Egger low power' and 'variants affect other lipid traits' points: both qualify interpretation but neither logically contradicts what the analyses *find* (balanced vs directional pleiotropy; a null test can coexist with the finding), so nodeing them under a contradiction edge would violate coherence; they are carried in the assessment prose and belong more to the parent exclusion-restriction claim. The 'MR-Egger low power' proposition was confirmed novel by the Matcher and is reusable, but left for the parent's steward or future creation. Set importance 0.3 (contestation 0.2): a notable supporting premise in a well-settled neighborhood; LDL causality is independently overdetermined by RCTs. Assessed SUPPORTED (confidence 0.85, credence 0.85) on convergent methodological literature: standard/MR-Egger/weighted-median analyses of LDL–CHD converge with a non-significant MR-Egger intercept, in explicit contrast to HDL where directional pleiotropy is detected. Not VERIFIED because of MR-Egger's low power and real non-directional pleiotropy handled only by modelling assumptions. marginal_yield 0.2.
Assessed Supported
verdict confidence 0.85 · credence 0.85
Mendelian randomization studies of low-density lipoprotein cholesterol (LDL) and cardiovascular disease consistently report no evidence of directional (unbalanced) pleiotropy, the form of pleiotropy that would bias a causal estimate in one direction. In analyses using genome-wide-significant lipid variants, standard inverse-variance-weighted, MR-Egger and weighted-median estimates converge on a causal effect of LDL on coronary heart disease, and the MR-Egger intercept, the standard test for directional pleiotropy, is not significant. This contrasts sharply with HDL cholesterol, where the same methods do detect directional pleiotropy and the apparent effect attenuates. The finding is reinforced by drug-target and multivariable analyses in which the LDL–disease association remains robust after adjusting for pleiotropic pathways. Two qualifications bound how much the finding proves rather than whether it holds. First, many LDL-associated variants also influence other lipid and metabolic traits, so pleiotropy is present; the claim is specifically that it is not *directional*, which is what the sensitivity tests assess, and such balanced or measurable pleiotropy is handled by outlier-robust and multivariable methods. Second, the MR-Egger intercept test has limited statistical power, so a null result is weaker evidence for the absence of directional pleiotropy than a positive result would be for its presence. Neither qualification overturns the consistent empirical pattern, which is why the finding is treated as supported rather than merely asserted.
Claim entered the graph